#BRAZIL MINISTER MORO’S FOLLOWERS: THE MOST EFFECTIVE ANTIVENOM AGAINST CORRUPTION
FACEBOOK GROUP LINK: https://www.facebook.com/groups/445892022859447/
SOURCE/LINK: https://youtu.be/PJXx8bdrw0A
#BRAZIL MINISTER MORO’S FOLLOWERS:
THE MOST EFFECTIVE ANTIVENOM AGAINST CORRUPTION
Antidote against any form of corruption orchestrated by national snakelike – rattlesnake =INTERCEPT and/or other foreign snakelike international organized crime alliance
#BRAZIL The snakelike striking to bite Minister Moro.
Snake bites compared in Slow Mo: Spectacled Cobra vs Saw Scaled Viper | BBC Earth
480.062 visualizações
3,8 mil 183 Compartilhar
Salvar
BBC Earth
Publicado em 18 de mar de 2018
Spectacled Cobra vs Saw Scaled Viper - which snake is striking to bite every time? Watch this amazing Slow Mo footage to find out. Subscribe for more amazing animal videos: http://bit.ly/BBCEarthSub Watch more videos from BBC Earth: Planet Earth http://bit.ly/PlanetEarthPlaylist Blue Planet http://bit.ly/BluePlanetPlaylist Planet Earth II http://bit.ly/PlanetEarthIIPlaylist Planet Dinosaur http://bit.ly/PlanetDinoPlaylist Natural World: India's Deadliest Snakes India has 275 species of snakes, more than any other country on the planet. Every year over one million Indians are bitten. Welcome to BBC EARTH: The world is an amazing place full of stories, beauty and natural wonder. You'll find 50 years worth of astounding, entertaining, thought-provoking and educational natural history content on here. Dramatic, rare, and exclusive, nature doesn't get more exciting than this. Want to share your views with the team behind BBC Earth and win prizes? Join our fan panel here: http://tinyurl.com/YouTube-BBCEarth-F... This is a channel from BBC Worldwide who help fund new BBC programmes Service information and feedback: http://bbcworldwide.com/vod-feedback-...
Categoria
Animais
==//==
SOURCE/LINK: http://www.butantan.gov.br/index
SOURCE/LINK: https://en.wikipedia.org/wiki/Antivenom
Participate in the Wiki Loves Earth Brasil 2019 photo contest
Submit photos about the Brazilian natural heritage and compete for several prizes
Antivenom
From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
For the comics character, see Anti-Venom (comics).
Antivenom
Milking a snake for the production of antivenom
Clinical data
Synonyms
antivenin, antivenene
AHFS/Drugs.com
Monograph
Routes of
administration
injection
ATC code
• J06
Identifiers
ChemSpider
• none
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings.[1] They are recommended only if there is significant toxicity or a high risk of toxicity.[1] The specific antivenom needed depends on the species involved.[1] It is given by injection.[1]
Side effects may be severe.[1] They include serum sickness, shortness of breath, and allergic reactions including anaphylaxis.[1] Antivenom is made by collecting venom from the relevant animal and injecting small amounts of it into a domestic animal.[2] The antibodies that form are then collected from the domestic animal's blood and purified.[2] Versions are available for spider bites, snake bites, fish stings, and scorpion stings.[3]
Antivenom was first developed in the late 1800s and came into common use in the 1950s.[2][4] They are on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.[5] Depending on the type, the wholesale cost in the developing world is US$9.00–118.80 per vial.[6] In the United States the wholesale cost is as high as $2,300 per dose.[7][8]
Contents
• 1 Medical uses
• 2 Mechanism
• 3 History
• 4 Availability
◦ 4.1 Spiders
◦ 4.2 Acarids
◦ 4.3 Insects
◦ 4.4 Scorpions
◦ 4.5 Marine animals
◦ 4.6 Snakes
• 5 Terminology
• 6 References
• 7 External links
Medical uses
The principle of antivenom is based on that of vaccines, developed by Edward Jenner; however, instead of inducing immunity in the patient directly, it is induced in a host animal and the hyperimmunized serum is transfused into the patient.[citation needed]
Antivenoms can be classified into monovalent (when they are effective against a single species' venom) or polyvalent (when they are effective against a range of species, or several different species at the same time).
Antivenoms for therapeutic use are often preserved as freeze-dried ampoules, but some are available only in liquid form and must be kept refrigerated. They are not immediately inactivated by heat, however, so a minor gap in the cold chain is not disastrous. The majority of antivenoms (including all snake antivenoms) are administered intravenously; however, stonefish and redback spider antivenoms are given intramuscularly. The intramuscular route has been questioned in some situations as not uniformly effective.[9]
Antivenoms bind to and neutralize the venom, halting further damage, but do not reverse damage already done. Thus, they should be administered as soon as possible after the venom has been injected, but are of some benefit as long as venom is present in the body. Since the advent of antivenoms, some bites which were previously invariably fatal have become only rarely fatal provided that the antivenom is administered soon enough.
Antivenoms are purified by several processes but will still contain other serum proteins that can act as antigens. Some individuals may react to the antivenom with an immediate hypersensitivity reaction (anaphylaxis) or a delayed hypersensitivity (serum sickness) reaction and antivenom should, therefore, be used with caution. Although rare, severe hypersensitivity reactions including anaphylaxis to antivenin are possible.[10] Despite this caution, antivenom is typically the sole effective treatment for a life-threatening condition, and once the precautions for managing these reactions are in place, an anaphylactoid reaction is not grounds to refuse to give antivenom if otherwise indicated. Although it is a popular myth that a person allergic to horses "cannot" be given antivenom, the side effects are manageable, and antivenom should be given as rapidly as the side effects can be managed.[11]
In the U.S., the only approved antivenom for pit viper (rattlesnake, copperhead and water moccasin) snakebite is based on a purified product made in sheep known as CroFab.[12] It was approved by the FDA in October, 2000. U.S. coral snake antivenom is no longer manufactured, and remaining stocks of in-date antivenom for coral snakebite expired in the Fall of 2009, leaving the U.S. without a coral snake antivenom. Efforts are being made to obtain approval for a coral snake antivenom produced in Mexico which would work against U.S. coral snakebite, but such approval remains speculative.[citation needed]
As an alternative when conventional antivenom is not available, hospitals sometimes use an intravenous version of the antiparalytic drug neostigmine to delay the effects of neurotoxic envenomation through snakebite.[13] Some promising research results have also been reported for administering the drug nasally as a "universal antivenom" for neurotoxic snakebite treatment.[14]
Mechanism
Antivenoms act by binding to and neutralizing venoms.
Although individuals can vary in their physiopathological response and sensitivity to animal venoms, there is no natural immunity to them in humans. Some ophiophagic animals are immune to the venoms produced by some species of venomous snakes, by the presence of antihemorrhagic and antineurotoxic factors in their blood.[citation needed]
It is quite possible to immunize a person directly with small and graded doses of venom rather than an animal. According to the Greek history, King Mithridates did this in order to protect himself against attempts of poisoning, therefore this procedure is often called mithridatism. However, unlike a vaccination against disease which must only produce a latent immunity that can be roused in case of infection, in order to neutralize a sudden and large dose of venom requires maintaining a high level of circulating antibody (a hyperimmunized state), through repeated venom injections (typically every 21 days). The long-term health effects of this process have not been studied. Further, cytotoxic venom components can cause pain and scarring at the immunization site. Finally, the resistance is specific to the used particular venom; maintaining resistance to a variety of venom requires multiple monthly venom injections. Thus, there is no practical purpose or favorable cost/benefit ratio for this, except for the people like zoo handlers, researchers, and circus artists who deal closely with venomous animals. Mithridatism has been tried with success in Australia and Brazil and total immunity has been achieved even to multiple bites of extremely venomous cobras and pit vipers.[citation needed]
Because neurotoxic venoms must travel farther in the body to do harm and are produced in smaller quantities, it is easier to develop resistance to them than directly cytotoxic venoms (such as those of most vipers) that are injected in large quantity and damage immediately upon injection.[citation needed]
History
The first antivenom for snakes (called an anti-ophidic serum) was developed by Albert Calmette, a French scientist of the Pasteur Institute working at its Indochine branch in 1895, against the Indian Cobra (Naja naja). In 1901, Vital Brazil, working at the Instituto Butantan in São Paulo, Brazil, developed the first monovalent and polyvalent antivenoms for Central and South American Crotalus and Bothrops genera, as well as for certain species of venomous spiders, scorpions, and frogs.[citation needed] In Australia, the Commonwealth Serum Laboratories (CSL) began antivenom research in the 1920s. CSL has developed antivenoms for the redback spider, funnel-web spiders and all deadly Australian snakes.[15]
Availability
There is an overall shortage of antivenom to treat snakebites. Because of this shortage, clinical researchers are looking at seeing if low doses can be as effective in severe neurotoxic snake envenoming.[16]
Internationally, antivenoms must conform to the standards of pharmacopoeia and the World Health Organization (WHO).[17] Antivenoms have been developed for the venoms associated with the following animals:[18]
Spiders
Antivenom
Species
Country
Funnel web spider antivenom
Sydney funnel-web spider
Australia
Soro antiaracnidico
Brazilian wandering spider
Brazil
Soro antiloxoscelico
Recluse spider
Brazil
Suero antiloxoscelico
Chilean recluse
Chile
Aracmyn
All species of Loxosceles and Latrodectus
Mexico
Redback spider antivenom
Redback spider
Australia
Black widow spider (Latrodectus Mactans) antivenin (equine origin)
Southern black widow spider
United States
SAIMR spider antivenom
Button spider
South Africa
Anti-Latrodectus antivenom
Black widow spider
Argentina
Acarids
Antivenom
Species
Country
Tick antivenom
Paralysis tick
Australia
Insects
Antivenom
Species
Country
soro antilonomico
Lonomia obliqua caterpillar
Brazil
Scorpions
Antivenom
Species
Country
Alacramyn
Centruroides limpidus, C. noxius, C. suffusus
Mexico
Suero Antialacran
Centruroides limpidus, C. noxius, C. suffusus
Mexico
Tunisian polyvalent antivenom
All Iranian scorpions
Tunisia
Anti-Scorpion Venom Serum I.P.(AScVS)
Indian red scorpion
India
Anti-scorpionique
Androctonus spp., Buthus spp.
Algeria
Scorpion antivenom
Black scorpion, Buthus occitanus
Morocco
Soro antiscorpionico
Tityus spp.
Brazil
SAIMR scorpion antivenin
Parabuthus spp.
South Africa
Purified prevalent Anti-Scorpion Serum(equine)
Leiurus spp. and Androctonus scorpions
Egypt
INOSCORPI MENA (Middle East and North Africa)
Androctonus australis hector, Androctonus mauritanicus, Androctonus australis garzoni, Buthus occitanus mardochei, Buthus occitanus occitanus, Leiurus quinquestriatus quinquestriatus, Leiurus quinquestriatus hebreus and related species.
Spain
Marine animals
Antivenom
Species
Country
CSL box jellyfish antivenom
Box jellyfish
Australia
CSL stonefish antivenom
Stonefish
Australia
Snakes
Antivenom
Species
Country
Polyvalent snake antivenom
South American rattlesnake Crotalus durissus and fer-de-lance Bothrops asper
Mexico (Instituto Bioclon); South America
INOSERP MENA
Bitis arietans, Cerastes cerastes, Naja haje, Macrovipera lebetina obtusa, Vipera palestinae, Naja pallida, Naja nigricollis, Walterinnesia aegyptia, Echis leucogaster, Macrovipera deserti, Cerastes vipera, Cerastes gasperettii, Echis coloratus, Echis pyrramidum, Echis khosatzkii, Echis sochureki, Echis megalocephalus, Echis omanensis, Echis carinatus sochureki, Macrovipera lebetina transmediterranea, Macrovipera lebetina turanica, Macrovipera mauritanica, Naja nubiae, Pseudocerastes persicus fieldi, Pseudocerastes persicus persicus, Vipera bornmuelleri, Vipera latastei, Vipera raddei kurdistanica
Spain
INOSERP Pan-Africa (Sub-Sahara)
Naja nigricollis, Dendroaspis polylepis, Echis ocellatus, Bitis arietans, Echis leucogaster, Echis pyramidum, Echis coloratus, Bitis gabonica, Bitis gabonica rhinoceros, Dendroaspis viridis, Dendroaspis angusticeps, Dendroaspis jamesoni, Naja haje, Naja pallida, Naja melanoleuca
Spain
Polyvalent snake antivenom
Saw-scaled viper Echis carinatus, Russell's viper Daboia russelli, spectacled cobra Naja naja, common krait Bungarus caeruleus
India
Death adder antivenom
Death adder
Australia
Taipan antivenom
Taipan
Australia
Black snake antivenom
Pseudechis spp.
Australia
Tiger snake antivenom
Australian copperheads, tiger snakes, Pseudechis spp., rough-scaled snake
Australia
Brown snake antivenom
Brown snakes
Australia
Polyvalent snake antivenom
Many Australian snakes
Australia
Sea snake antivenom
Sea snakes
Australia
Vipera tab
Vipera spp.
UK
Polyvalent crotalid antivenin (CroFab—Crotalidae Polyvalent Immune Fab (Ovine))
North American pit vipers (all rattlesnakes, copperheads, and cottonmouths)
North America
Soro antibotropicocrotalico
Pit vipers and rattlesnakes
Brazil
Antielapidico
Coral snakes
Brazil
SAIMR polyvalent antivenom
Mambas, cobras, Rinkhalses, puff adders (Unsuitable small adders: B. worthingtoni, B. atropos, B. caudalis, B. cornuta, B. heraldica, B. inornata, B. peringueyi, B. schneideri, B. xeropaga)
South Africa[19]
SAIMR echis antivenom
Saw-scaled vipers
South Africa
SAIMR Boomslang antivenom
Boomslang
South Africa
Panamerican serum
Coral snakes
Costa Rica
Anticoral
Coral snakes
Costa Rica
Anti-mipartitus antivenom
Coral snakes
Costa Rica
Anticoral monovalent
Coral snakes
Costa Rica
Antimicrurus
Coral snakes
Argentina
Coralmyn
Coral snakes
Mexico
Anti-micruricoscorales
Coral snakes
Colombia
Terminology
The name "antivenin" comes from the French word venin, meaning venom, which in turn was derived from Latin venenum, meaning poison.[citation needed]
Historically, the term antivenin was predominant around the world, its first published use being in 1895.[20] In 1981, the World Health Organization decided that the preferred terminology in the English language would be venom and antivenom rather than venin and antivenin or venen and antivenene.[21]
References
1.
• WHO Model Formulary 2008 (PDF). World Health Organization. 2009. pp. 396–397. ISBN 9789241547659. Archived (PDF) from the original on 13 December 2016. Retrieved 8 January 2017.
• Dart, Richard C. (2004). Medical Toxicology. Lippincott Williams & Wilkins. pp. 250–251. ISBN 9780781728454. Archived from the original on 2017-01-09.
• British national formulary : BNF 69 (69 ed.). British Medical Association. 2015. p. 43. ISBN 9780857111562.
• Gad, Shayne Cox (2007). Handbook of Pharmaceutical Biotechnology. John Wiley & Sons. p. 692. ISBN 9780470117101. Archived from the original on 2017-01-09.
• "WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016.
• "Antivenom Serum". International Drug Price Indicator Guide. Archived from the original on 27 February 2017. Retrieved 8 December 2016.
• Lewis, Danny (11 September 2015). "Why A Single Vial Of Antivenom Can Cost $14,000". Smithsonian. Retrieved 9 January 2017.
• "One step closer to cheaper antivenom". ScienceDaily. 3 September 2015. Archived from the original on 9 January 2017. Retrieved 9 January 2017.
• Isbister GK. (2002). "Failure of intramuscular antivenom in Redback spider envenoming". Emerg Med (Fremantle). 14 (4): 436–9. doi:10.1046/j.1442-2026.2002.00356.x. PMID 12534488.
• Bhoite RR, Bhoite GR, Bagdure DN, Bawaskar HS (2015). "Anaphylaxis to scorpion antivenin and its management following envenomation by Indian red scorpion, Mesobuthus tamulus". Indian Journal of Critical Care Medicine. 19 (9): 547–549. doi:10.4103/0972-5229.164807. PMC 4578200.
• See, for example, the Antivenom Precautions paragraph of the Medication section of James Forster (2006-03-14). "Snake Envenomations, Sea". eMedicine Emergency Medicine (environmental). Archived from the original on 26 June 2006. Retrieved 2006-06-25.
• "Archived copy". Archived from the original on 2016-03-03. Retrieved 2016-02-08. Link to PDF for full prescribing information, retrieved 11/11/12
• Franklin, Deborah, "Potential Treatment For Snakebites Leads To A Paralyzing Test Archived 2014-08-09 at the Wayback Machine", NPR.org, July 31, 2013.
• "Universal antidote for snakebite: Experimental trial represents promising step Archived 2014-07-07 at the Wayback Machine", California Academy of Sciences via Science Daily, May 28, 2014.
• "CSL antivenoms 1956". Power House Museum. Archived from the original on 7 August 2016. Retrieved 24 February 2017.
• Agarwal, R; Aggarwal, AN; Gupta, D; Behera, D; Jindal, SK (June 2005). "Low dose of snake antivenom is as effective as high dose in patients with severe neurotoxic snake envenoming". Emergency Medicine Journal. 22 (6): 397–9. doi:10.1136/emj.2004.020727. PMC 1726801. PMID 15911942.
• Theakston RD, Warrell DA, Griffiths E (April 2003). "Report of a WHO workshop on the standardization and control of antivenoms". Toxicon. 41 (5): 541–57. doi:10.1016/S0041-0101(02)00393-8. PMID 12676433.
• "Appendix: Antivenom Tables". Clinical Toxicology. 41 (3): 317–27. 2003. doi:10.1081/CLT-120021117.
• Spawls, S; Branch B (1995). The Dangerous Snakes of Africa. Ralph Curtis Books. Dubai: Oriental Press. p. 192. ISBN 0-88359-029-8.
• "Antivenin". Merriam-Webster Dictionary.
21. World Health Organization (1981). Progress in the characterization of venoms and standardization of antivenoms. Geneva: WHO Offset Publications. p. 5. ISBN 92-4-170058-0.
External links
• Antivenom Index, a joint project of the Association of Zoos and Aquariums and the American Association of Poison Control Centers which helps locate rare antivenoms
• Venom Response Program of the Miami-Dade Fire Rescue service
• v
• t
• e
Immune sera and immunoglobulins (J06)
Polyclonal antibodies
IVIG
• Anthrax immune globulin
• Rho(D) immune globulin
• Hepatitis B immune globulin
• Zoster-immune globulin
Antiserum
• Antivenom
Monoclonal antibodies
• Motavizumab
• Nebacumab
• Palivizumab
• Raxibacumab
• Pharmacy and pharmacology portal
• Medicine portal
Categories:
• Toxicology treatments
• Polyclonal antibodies
• Antitoxins
• World Health Organization essential medicines
Navigation menu
• Not logged in
• Talk
• Contributions
• Create account
• Log in
• Article
• Talk
• Read
• Edit
• View history
Search
• Main page
• Contents
• Featured content
• Current events
• Random article
• Donate to Wikipedia
• Wikipedia store
Interaction
• Help
• About Wikipedia
• Community portal
• Recent changes
• Contact page
Tools
• What links here
• Related changes
• Upload file
• Special pages
• Permanent link
• Page information
• Wikidata item
• Cite this page
Print/export
• Create a book
• Download as PDF
• Printable version
Languages
• العربية
• Deutsch
• Español
• Français
• हिन्दी
• Bahasa Melayu
• Polski
• Türkçe
• Tiếng Việt
Edit links
• This page was last edited on 23 May 2019, at 16:12 (UTC).
• Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
• Privacy policy
• About Wikipedia
• Disclaimers
• Contact Wikipedia
• Developers
• Cookie statement
• Mobile view
•
•
THE END
Comentários
Postar um comentário